Cargando…

Change in Antidepressant Use After Initiation of ADHD Medication in Japanese Adults with Comorbid Depression: A Real-World Database Analysis

PURPOSE: To better understand the treatment of comorbid depression in adults with attention-deficit/hyperactivity disorder (ADHD) by investigating the prescription patterns of antidepressants, anxiolytics, and hypnotics after commencing ADHD medication. PATIENTS AND METHODS: In this retrospective ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Chika, Tsuji, Toshinaga, Nakai, Toru, Namba, Yuki, Mishima, Hirokazu, Fujiwara, Masakazu, Matsunaga, Hisato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520036/
https://www.ncbi.nlm.nih.gov/pubmed/34675521
http://dx.doi.org/10.2147/NDT.S325498
_version_ 1784584581227216896
author Sakai, Chika
Tsuji, Toshinaga
Nakai, Toru
Namba, Yuki
Mishima, Hirokazu
Fujiwara, Masakazu
Matsunaga, Hisato
author_facet Sakai, Chika
Tsuji, Toshinaga
Nakai, Toru
Namba, Yuki
Mishima, Hirokazu
Fujiwara, Masakazu
Matsunaga, Hisato
author_sort Sakai, Chika
collection PubMed
description PURPOSE: To better understand the treatment of comorbid depression in adults with attention-deficit/hyperactivity disorder (ADHD) by investigating the prescription patterns of antidepressants, anxiolytics, and hypnotics after commencing ADHD medication. PATIENTS AND METHODS: In this retrospective observational study in Japan, the data of patients initiating ADHD medication while already receiving antidepressants (ADHD group) and of patients prescribed antidepressants but not diagnosed with ADHD (control group) were extracted from an electronic medical record database. Additionally, one-to-one matching for patients in both groups was performed using sex, age, baseline dosage of antidepressants, and any comorbid psychiatric disorders as covariates. The observation period included a 1-month baseline period and a 6-month follow-up period. The percentage of patients prescribed antidepressants and the mean prescribed dosages were compared between matched-cohort groups. Prescriptions for anxiolytics and hypnotics were also assessed. RESULTS: In the matched cohorts, consisting of 239 patients in the ADHD group and 239 patients from the unmatched control cohort of 10,485, the percentage of patients prescribed antidepressants decreased from baseline in both groups to 94.1% in the ADHD group and 89.5% in the control group during the first month of follow-up, and 77.0% and 78.7%, respectively, during the last month. There were no significant differences between groups in the percentages of patients prescribed antidepressants or in the mean prescribed dosages of antidepressants at any time point over the follow-up period. Prescribed dosages of anxiolytics and hypnotics tended to be lower in the ADHD group. CONCLUSION: The two groups were medicated similarly with respect to their depressive symptoms over 6 months. Our results suggest that in patients with ADHD and comorbid depression, which is more likely to be more severe than in depression without ADHD, depressive symptoms are managed following initiation of add-on ADHD medication, without requiring higher antidepressant dosages than in patients with depression only.
format Online
Article
Text
id pubmed-8520036
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85200362021-10-20 Change in Antidepressant Use After Initiation of ADHD Medication in Japanese Adults with Comorbid Depression: A Real-World Database Analysis Sakai, Chika Tsuji, Toshinaga Nakai, Toru Namba, Yuki Mishima, Hirokazu Fujiwara, Masakazu Matsunaga, Hisato Neuropsychiatr Dis Treat Original Research PURPOSE: To better understand the treatment of comorbid depression in adults with attention-deficit/hyperactivity disorder (ADHD) by investigating the prescription patterns of antidepressants, anxiolytics, and hypnotics after commencing ADHD medication. PATIENTS AND METHODS: In this retrospective observational study in Japan, the data of patients initiating ADHD medication while already receiving antidepressants (ADHD group) and of patients prescribed antidepressants but not diagnosed with ADHD (control group) were extracted from an electronic medical record database. Additionally, one-to-one matching for patients in both groups was performed using sex, age, baseline dosage of antidepressants, and any comorbid psychiatric disorders as covariates. The observation period included a 1-month baseline period and a 6-month follow-up period. The percentage of patients prescribed antidepressants and the mean prescribed dosages were compared between matched-cohort groups. Prescriptions for anxiolytics and hypnotics were also assessed. RESULTS: In the matched cohorts, consisting of 239 patients in the ADHD group and 239 patients from the unmatched control cohort of 10,485, the percentage of patients prescribed antidepressants decreased from baseline in both groups to 94.1% in the ADHD group and 89.5% in the control group during the first month of follow-up, and 77.0% and 78.7%, respectively, during the last month. There were no significant differences between groups in the percentages of patients prescribed antidepressants or in the mean prescribed dosages of antidepressants at any time point over the follow-up period. Prescribed dosages of anxiolytics and hypnotics tended to be lower in the ADHD group. CONCLUSION: The two groups were medicated similarly with respect to their depressive symptoms over 6 months. Our results suggest that in patients with ADHD and comorbid depression, which is more likely to be more severe than in depression without ADHD, depressive symptoms are managed following initiation of add-on ADHD medication, without requiring higher antidepressant dosages than in patients with depression only. Dove 2021-10-11 /pmc/articles/PMC8520036/ /pubmed/34675521 http://dx.doi.org/10.2147/NDT.S325498 Text en © 2021 Sakai et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Sakai, Chika
Tsuji, Toshinaga
Nakai, Toru
Namba, Yuki
Mishima, Hirokazu
Fujiwara, Masakazu
Matsunaga, Hisato
Change in Antidepressant Use After Initiation of ADHD Medication in Japanese Adults with Comorbid Depression: A Real-World Database Analysis
title Change in Antidepressant Use After Initiation of ADHD Medication in Japanese Adults with Comorbid Depression: A Real-World Database Analysis
title_full Change in Antidepressant Use After Initiation of ADHD Medication in Japanese Adults with Comorbid Depression: A Real-World Database Analysis
title_fullStr Change in Antidepressant Use After Initiation of ADHD Medication in Japanese Adults with Comorbid Depression: A Real-World Database Analysis
title_full_unstemmed Change in Antidepressant Use After Initiation of ADHD Medication in Japanese Adults with Comorbid Depression: A Real-World Database Analysis
title_short Change in Antidepressant Use After Initiation of ADHD Medication in Japanese Adults with Comorbid Depression: A Real-World Database Analysis
title_sort change in antidepressant use after initiation of adhd medication in japanese adults with comorbid depression: a real-world database analysis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520036/
https://www.ncbi.nlm.nih.gov/pubmed/34675521
http://dx.doi.org/10.2147/NDT.S325498
work_keys_str_mv AT sakaichika changeinantidepressantuseafterinitiationofadhdmedicationinjapaneseadultswithcomorbiddepressionarealworlddatabaseanalysis
AT tsujitoshinaga changeinantidepressantuseafterinitiationofadhdmedicationinjapaneseadultswithcomorbiddepressionarealworlddatabaseanalysis
AT nakaitoru changeinantidepressantuseafterinitiationofadhdmedicationinjapaneseadultswithcomorbiddepressionarealworlddatabaseanalysis
AT nambayuki changeinantidepressantuseafterinitiationofadhdmedicationinjapaneseadultswithcomorbiddepressionarealworlddatabaseanalysis
AT mishimahirokazu changeinantidepressantuseafterinitiationofadhdmedicationinjapaneseadultswithcomorbiddepressionarealworlddatabaseanalysis
AT fujiwaramasakazu changeinantidepressantuseafterinitiationofadhdmedicationinjapaneseadultswithcomorbiddepressionarealworlddatabaseanalysis
AT matsunagahisato changeinantidepressantuseafterinitiationofadhdmedicationinjapaneseadultswithcomorbiddepressionarealworlddatabaseanalysis